For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Joji Nakayama, President and CEO
(Code no.: 4568, First Section of Tokyo and Osaka Stock Exchanges)
Please address inquiries to Noriaki Ishida, Corporate Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com
Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology Awards Its 6th Annual Clinical Pharmacology Research Award
Tokyo, Japan (June 25, 2013) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Kiyoshi Morita), has awarded its 6th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.
Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation. Innovative research projects with expectations for future development are eligible for the award.
The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 5, 2013.
*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research, overseas studies for Japanese researchers, and international collaborations in Asia.
Recipients of the 6th Japan Research Foundation for Clinical Pharmacology Research Award
|
Recipient
|
Organization
|
Research theme
|
|
Yuji Ishii
|
Laboratory of Molecular Life Sciences
Graduate School of Pharmaceutical Sciences
Kyushu University
|
Novel mechanism of inter-individual difference in drug responses: modulation of cytochrome P450 3A4 function by UDP-glucuronosyltransferases
|
|
Mitsushige Sugimoto
|
Division of Gastroenterology
First Department of Medicine
Hamamatsu University School of Medicine
|
Effectiveness of personalized eradication treatment for patients infected with Helicobacter pylori
|
|
Masayoshi Souri
|
Department of Molecular Patho-Biochemistry
and Patho- Biology,
Yamagata University School of Medicine
|
Change in the plasma levels of protein Z system,
a novel anti-activated factor X system
|
|
Hiroshi Furukawa
|
Clinical Research Center for Allergy
and Rheumatology,
Sagamihara Hospital,
National Hospital Organization
|
Genetic association study on drug-induced interstitial lung diseases in rheumatoid arthritis patients
|
|
Hiroyuki Mizuguchi
|
Department of Biochemistry
and Molecular Biology,
Graduate School of Pharmaceutical Sciences,
Osaka University
|
Development of mature hepatocytes derived from human ES/iPS cells and prediction of drug-induced liver toxicities
|